NCT02438865View on ClinicalTrials.gov

Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

May 1, 2018

Study Completion Date

May 30, 2018

Conditions
Neoplasm, UreterNeoplasm, Bladder
Interventions
DRUG

Immediate instillation of intravesical chemotherapy-Epirubicin-

DRUG

Maintainance therapy of intravesical chemotherapy-Epirubicin-

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT02438865 - Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy. | Biotech Hunter | Biotech Hunter